Be Biopharma
Latest round
- Series C
Last raised
- Jan 2025
Total raised
- $203M
Investors
- 8
About Be Biopharma
Based in the US, Be Biopharma, Inc.Founded in 2020, Be Biopharma, Inc. is located in Cambridge, US. The company focuses on developing innovative therapies for hemophilia B, enabling enhanced blood-clotting factor production.00 mn.Be Biopharma specializes in the development and commercialization of engineered B cell medicines, focusing on innovative protein-based therapies aimed at addressing serious diseases such as hemophilia B. The company's core offerings leverage advanced scientific strategies to create therapies that enhance the body's ability to produce necessary blood-clotting factors, transforming the treatment landscape for patients. These therapies are designed to provide greater freedom and improved health outcomes for individuals living with hemophilia B, significantly impacting their quality of life.Be Biopharma's revenue structure is based on partnerships and collaborations with healthcare institutions and research organizations. Transactions typically occur through direct engagements with healthcare providers and specialty pharmacies, facilitating the distribution of their proprietary therapies. The company utilizes subscription models or negotiated pricing agreements to ensure access to its flagship therapies, which are essential for managing hemophilia B.In January 2025, Be Biopharma, Inc. The company plans to design and launch new products targeting this condition, while also expanding its market presence into additional regions. Specific geographic areas targeted for growth include new territories within North America and Europe by the end of 2025.
Who invested in Be Biopharma
8 investors across 3 rounds
See all investors in Be Biopharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Be Biopharma
Who invested in Be Biopharma?
Be Biopharma has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Be Biopharma raised?
Be Biopharma has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Be Biopharma last raise money?
Be Biopharma's most recent round on record is a Series C, in Jan 2025.
What does Be Biopharma do?
Based in the US, Be Biopharma, Inc.
Where is Be Biopharma headquartered?
Be Biopharma is headquartered in Cambridge, US.
Which VCs invest in companies like Be Biopharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Be Biopharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Be Biopharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.